Menarini Ricerche to Present the Most Recent Pre-clinical Data...
- Written by LATEST ASIANET NEWS RELEASES
- Category: Asia Net
POMEZIA, Italy, April 13, 2018 /PRNewswire-AsiaNet/ -- Menarini Ricerche will present on the latest preclinical studies of its phosphatidylinositol 3-kinase (PI3K) class I inhibitor MEN1611, in development for solid tumors, at the AACR Annual Meeting 2018, which will take place on April 14-18, 2018, i......




